Skip to main content
Livermore
Livermore
ZHEN

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

ALDX holding history

Aldeyra Therapeutics, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALDX overviewAll 13F holders of ALDXFull Q2 2026 holdings

Shares (Q2 2026)
379,144
Value
$807.6K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ALDX by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026379,144$807.6K<0.1%+112,804+42.4%AddedHolders
Q1 2026266,340$450.1K<0.1%+266,340NewHolders
Q4 20250$00.0%−152,254−100.0%Sold outHolders
Q3 2025152,254$794.8K<0.1%+139,800+1,122.5%AddedHolders
Q2 202512,454$47.7K<0.1%+12,454NewHolders
Q1 20250$00.0%−85,642−100.0%Sold outHolders
Q4 202485,642$427.4K<0.1%+31,491+58.2%AddedHolders
Q3 202454,151$291.9K<0.1%+44,587+466.2%AddedHolders
Q2 20249,564$31.7K<0.1%−45,684−82.7%ReducedHolders
Q1 202455,248$180.7K<0.1%−12,481−18.4%ReducedHolders
Q4 202367,729$237.7K<0.1%−222,070−76.6%ReducedHolders
Q3 2023289,799$1.94M<0.1%+134,651+86.8%AddedHolders
Q2 2023155,148$1.30M<0.1%−33,095−17.6%ReducedHolders
Q1 2023188,243$1.87M<0.1%−521,910−73.5%ReducedHolders
Q4 2022710,153$4.94M<0.1%−953,975−57.3%ReducedHolders
Q3 20221,664,128$8.89M<0.1%−654,050−28.2%ReducedHolders
Q2 20222,318,178$9.25M<0.1%−161,358−6.5%ReducedHolders
Q1 20222,479,536$11.0M<0.1%+2,190,919+759.1%AddedHolders
Q4 2021288,617$1.15M<0.1%+240,484+499.6%AddedHolders
Q3 202148,133$423.0K<0.1%+20,056+71.4%AddedHolders
Q2 202128,077$318.0K<0.1%−229,315−89.1%ReducedHolders
Q1 2021257,392$3.06M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.